Leadership & Pay ·
Theravance Biopharma Ireland Limited entered into a compromise agreement with Áine Miller, Senior Vice President…
TBPHTheravance Biopharma, Inc.
Theravance Biopharma Ireland Limited entered into a compromise agreement with Áine Miller, Senior Vice President, Development and Head of Ireland Office, regarding her termination on November 15, 2026. This departure is part of a restructuring announced in March 2026. Under the agreement, the company will make a $250,000 special pension contribution within 30 days of the termination date. Dr. Miller also received a grant of 18,750 restricted share units on June 19, 2026, to ensure continued service through her departure date. Theravance Biopharma is a biopharmaceutical company.